Skip to main content
. 2021 Nov 28;26(23):7216. doi: 10.3390/molecules26237216

Table 5.

Antiviral activity of cannabinoids against Corona Virus.

Corona Virus Group Compound Activity (µM) Reference Drug Activity (μM) Ref
hCov-OC43 Caflanone EC50 0.42 [184]
SARS-CoV-2 (spike positive) CBD EC50 0.64–1.79 [195]
SARS-CoV-2 in A549-ACE2 7-OH-CBD EC50 3.6 [195]
SARS-CoV-2 CBD, THC, CBN, CBDA, THCA IC50 7.91–37.61 Remdesivir, Lopinavir and Chloroquine IC50 8.17–13.16 [189]